-+ 0.00%
-+ 0.00%
-+ 0.00%

FORTRESS BIOTECH: CYPRIUM TO RETAIN OWNERSHIP OVER ANY PRV UPON NDA APPROVAL, TO RECEIVE ROYALTIES & UP TO $129 MLN IN MILESTONES

Reuters·11/17/2025 12:32:57

Please log in to view news